AXYCEF 125mg/5ml powder for oral suspension SANDOZ
cefuroxime Indicated for: bacterial infections
letter A · page 105
cefuroxime Indicated for: bacterial infections
cefuroxime Indicated for: bacterial infections
cefuroxime Indicated for: bacterial infections
cefuroxime Indicated for: bacterial infections
mycophenolate Indicated for: prevention of transplant rejection
mycophenolate Indicated for: prevention of transplant rejection
avapritinib Indicated for: gastrointestinal stromal tumors; systemic mastocytosis
avapritinib Indicated for: gastrointestinal stromal tumors; systemic mastocytosis
avapritinib Indicated for: gastrointestinal stromal tumors; systemic mastocytosis
avapritinib Indicated for: gastrointestinal stromal tumors; systemic mastocytosis
avapritinib Indicated for: gastrointestinal stromal tumors; systemic mastocytosis
azacitidine Indicated for: myelodysplastic syndromes; acute myeloid leukemia
L01BC07 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
azacitidine Indicated for: myelodysplastic syndromes; acute myeloid leukemia
L01BC07 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
azacitidine Indicated for: myelodysplastic syndromes; acute myeloid leukemia
L01BC07 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
azacitidine Indicated for: myelodysplastic syndromes; acute myeloid leukemia
L01BC07 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
azacitidine Indicated for: myelodysplastic syndromes; acute myeloid leukemia
L01BC07 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
azacitidine Indicated for: myelodysplastic syndromes; acute myeloid leukemia
L01BC07 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
azacitidine Indicated for: myelodysplastic syndromes; acute myeloid leukemia
L01BC07 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
azacitidine Indicated for: myelodysplastic syndromes; acute myeloid leukemia
L01BC07 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues
azacitidine Indicated for: myelodysplastic syndromes; acute myeloid leukemia
L01BC07 Antineoplastic and immunomodulating agents | Antimetabolites | Pyrimidine analogues